ADVANCES IN CELL AND GENE THERAPY: Vol 3, No 4

One possible mechanism of relapsed disease is the downregulation of surface B-cell maturation antigen (BCMA) by gamma secretase. The gamma secretase inhibitor (JSMD194) can increase surface BCMA expression and decrease soluble BCMA.

EXPERT PERSPECTIVE

Full Access

COVID-19 & allogeneic transplant: Activity and preventive measures for best outcomes in China

Zheng-Li Xu, Xiao-Jun Huang,

e94
First Published: 01 June 2020

Sign up for email alerts

Enter your email to receive alerts when new articles and issues are published.

Email address

Please select your location and accept the terms of use.

Country or location

I consent to Wiley Online Library’s Terms of Use and processing of my personal data as disclosed in Wiley’s Privacy Policy.I consent to my personal information being transferred outside of the People’s Republic of China as laid out in Wiley’s Privacy Policy.*(Optional) I consent to special offers, newsletter & promotions from Wiley. See Privacy Policy for more details.